Tumor-to-tumor metastasis (TTM) is a rare phenomenon and usually involves urological malignancies. This case report describes a 68-year-old female with end stage metastatic breast cancer that underwent excision of thoracic intradural tumor. Histopathological analysis of the lesion revealed two separate cell population. This is the first documented case of TTM seen going to the spine.
inTRoduCTion
The intriguing phenomenon that is tumor-to-tumor metastasis (TTM) was first described in 1902 by Berent and a comprehensive review of case reports was done by Campbell in 1968. In Campbell's series, he defined the following criteria: (1) more than one primary tumor must exist, (2) recipient tumor must be a true malignant or benign neoplasm, (3) there must not be contiguous growth (local spread) or emobolization of tumor cells, (4) tumors that metastasize to the lymphatic system where lymphoreticular malignant tumors already exist. Our case describes the first documented case of TTM where the recipient site is the thoracic spine.
CASe RepoRT
A 68-year-old female was admitted to hospital under the oncology service for ongoing management of end stage metastatic breast cancer. She had previously undergone a radical right sided mastectomy with adjuvant chemo/ radiotherapy some 10 years earlier. Neurosurgical consultation with sought in regards to her lower limb weakness 10.5005/jp-journals-10039-1018 and hyperreflexia. On examination, she was resting in bed with 4/5 power bilaterally in her lower limbs, brisk ankle jerk reflexes and otherwise neurologically intact. Urgent magnetic resonance imaging (MRI) scan showed a nodular intradural lesion with extramedullary deposits evident (Fig. 1) . There was no significant canal stenosis nor any cord signal change. Two days later, she underwent a resection of the T10/11 intradural lesion. T10 laminectomy was performed followed by dural opening using the operating microscope. Arachnoid was opened to reveal bilobed tumor ventral to the cord, attached to thickened pia/rootlet (Fig. 2) . The tumor was divided into two parts and removed. The dura was closed reinforced with fibrin sealant and surgicel.
Intraoperative frozen section was not available at the time of surgery due to the procedure being carried out on a weekend. Postoperatively, our patient was transferred to intensive care where she lay flat for 48 hours due to the dural opening. Over the next 5 days, she regained her lower limb power and suffered no complications from surgery.
HiSTopATHoLogy
The T10/11 bilobed tumor seen at the time of operation was completely removed and sent for histopathology. The tissue was received as two pieces of firm tan tissue 12 × 5 × 4 mm and 10 × 5 × 4 mm. The tissue was stained with hematoxylin and eosin (H & E) and was microscopically examined on multiple levels cut at a 4 μm thickness. The bulk of the unencapsulated tissue showed a background nerve sheath tumor with densely packed bland tapered spindle cells arranged in fascicles. There were two small vessels seen with hyalinized walls. There were no distinct Antoni A or Antoni B areas, no verocay bodies, no necrosis, no foamy macrophages or hemosiderin deposition and no myxoid change or mast cells. The nerve sheath tumor stained pericellularly with reticulin. immunohistochemistry was performed to identify the origin of both tumors. 1 The nerve sheath tumor was diffusely positive for S100 and negative for epithelial membrane antigen (EMA). Neuro filaments highlighted scatted aligned axons. Given the lack of morphological schwannoma features and the alignment of the neurofilaments, the appearances were consistent with a neurofibroma (Fig. 3) . 2 The poorly differentiated adenocarcinoma was positive for AE1/AE3 and EMA, weakly positive for progesterone receptor (PR) (in 25% of cells) and was initially negative for estrogen receptor (ER), however a repeat stain showed moderate positivity (in 10% of cells) (Fig. 4) . The adenocarcinoma was also negative for E-cadherin, paired box gene 8 (PAX8), caudal type homebox 2 (CDX2) and transcription termination factor 1 (TTF1). Human epidermal growth factor receptor-2 (HER-2) immunohistochemistry and silver in situ hybridization (SISH) status was performed on this case and was found to be negative. This staining pattern confirms the tumor to be of breast origin and is of pleomorphic lobular morphology. 3 The previous histopathology from the original breast carcinoma diagnosis was unavailable for comparison.
In addition, there was also an infiltration of metastatic poorly differentiated adenocarcinoma with intracytoplasmic mucin droplets seen. The invasive cells were arranged in aggregates, cords and as single cells. The nuclei were pleomorphic with frequent mitoses and there was no distinct tubule formation. Given the strict previously established criteria for TTm,
